Targeting MUC1-C reverses the cisplatin resistance of esophageal squamous cell carcinoma in vitro and in vivo

BACKGROUND: The efficacy of chemotherapeutic treatment of esophageal squamous cell carcinoma (ESCC) is limited by drug resistance during. This severely compromises the long-term survival rate of patients. Therefore, reversing chemotherapy resistance in ESCC may improve the therapeutic outcome. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yong-Qiang, Wu, Ting, Wang, Li-Feng, Yin, Bo, Shi, Mo, Jiang, Bin, Gong-Sun, Xin, Song, Xue-Min, Liu, Xiang-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799139/
https://www.ncbi.nlm.nih.gov/pubmed/35116398
http://dx.doi.org/10.21037/tcr-20-2495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799139/
https://www.ncbi.nlm.nih.gov/pubmed/35116398
http://dx.doi.org/10.21037/tcr-20-2495

Ejemplares similares